Join
Live feed
·
INSIDERFilingvia Quantisnow
Damora Therapeutics Inc. logo

Director, President and CEO Jarrett Jennifer bought $252,875 worth of Ordinary Shares (12,500 units at $20.23), increasing direct ownership by 2% to 512,500 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
DMRA· Damora Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DMRA (Damora Therapeutics Inc.) and more on Quantisnow.